Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein. Scientists at St.

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer retrieved 19 March 2024 from https://medicalxpress.com/news/2024-03-immunotherapy-cancer-fusion-protein-key.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Jul 28, 2021 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapyTherapeutic cancer vaccines are a form of immunotherapy in the making that could not only destroy cancer cells in patients, but keep a cancer from coming back and spreading.
Source: NewsMedical - 🏆 19. / 71 Read more »

Circulating tumor DNA levels predict outcomes for gastroesophageal cancer treated with immunotherapyMonitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg–Kimmel Institute for Cancer...
Source: medical_xpress - 🏆 101. / 51 Read more »

Protein 'brake' could help develop new cancer treatmentsSome cancerous tumors hijack proteins that act as 'brakes' on our immune system and use them to form a sort of shield against immune recognition. Immunotherapy treatments have been created that turn off these 'brakes' and allow our body to attack foreign-looking cancer cells.
Source: medical_xpress - 🏆 101. / 51 Read more »